Form 4: Hims & Hers CEO Sells Shares, Exercises Options

Hims & Hers Health, Inc. CEO Andrew Dudum reported significant sales of Class A Common Stock and exercise of stock options, primarily under a Rule 10b5-1 trading plan.

Summary

• Andrew Dudum, Chief Executive Officer, Director, and 10% Owner of Hims & Hers Health, Inc. (HIMS), reported multiple transactions on September 15 and 16, 2025.
• All stock option exercises and sales were executed pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024.
• Acquired a total of 164,368 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Acquired a total of 125,335 shares of Class A Common Stock by exercising stock options at a price of $2.43 per share.
• Disposed of 90,672 shares of Class A Common Stock at $53.96 to cover tax withholding obligations in connection with RSU vesting.
• Sold a total of 175,661 shares of Class A Common Stock at weighted average prices ranging from $52.8953 to $54.2115.
• Following these transactions, direct beneficial ownership of Class A Common Stock stands at 160,425 shares.
• Indirect beneficial ownership of Class A Common Stock through various family trusts totals 8,136,813 shares.
• Beneficially owns 1,296,568 Restricted Stock Units and 573,735 Stock Options after the reported transactions.

Sentiment

Score: 4

Explanation: The CEO engaged in significant sales of Class A Common Stock, which can be viewed negatively by the market. However, these transactions were part of a pre-arranged 10b5-1 trading plan, and also included the exercise of deeply in-the-money stock options, which is a positive for the executive. The net effect on sentiment is moderately negative due to the scale of sales.

Positives

• CEO Andrew Dudum exercised stock options at a low price of $2.43 per share, indicating a significant in-the-money position and personal gain.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, suggesting a systematic approach to managing personal holdings rather than a reaction to immediate market conditions.

Negatives

• CEO Andrew Dudum sold a substantial number of Class A Common Stock shares, totaling 175,661 shares, in addition to 90,672 shares withheld for tax obligations.
• The sales occurred at weighted average prices ranging from $52.8953 to $54.2115, representing a significant liquidation of direct holdings.

Future Outlook

NA

Management Comments

• The stock option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024, indicating a pre-scheduled approach to managing equity holdings.

Industry Context

NA

Stakeholder Impact

• Shareholders may perceive the significant insider selling as a negative signal, although the pre-arranged 10b5-1 plan mitigates some of the immediate concern.

Key Dates

Recommendation

The filing indicates significant insider selling by the CEO, which typically signals a lack of confidence. However, the sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to liquidity rather than a reaction to immediate negative news. The CEO also exercised a substantial number of deeply in-the-money stock options, which is a positive for the executive. Without further information on the company's operational performance or strategic outlook, a 'hold' recommendation is appropriate, acknowledging both the potential negative signal of insider sales and the mitigating factor of the 10b5-1 plan.

Keywords

Hims & Hers, HIMS, Andrew Dudum, Insider Trading, Stock Sale, Stock Option Exercise, RSU Vesting, Form 4, 10b5-1 Plan